Mevac-A vaccine
PED-2566-0634
Phase 3 mab completed
Quick answer
Mevac-A vaccine for HAV is a Phase 3 program (mab) at Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
- Indication
- HAV
- Phase
- Phase 3
- Modality
- mab
- Status
- completed